| Rebecca Street, DO | |
|
147 Towne Square Way, Pittsburgh, PA 15227 | |
| (412) 942-1085 | |
| Not Available |
| Full Name | Rebecca Street |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 10 Years |
| Location | 147 Towne Square Way, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154737922 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5101021434 (Michigan) | Secondary |
| 207V00000X | Obstetrics & Gynecology | OS020145 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Allegheny General Hospital | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allegheny Clinic | 5395649586 | 1941 |
News Archive
A 30 year old woman diagnosed with breast cancer has the same chance of survival as a 60 year old woman with breast cancer according to the latest findings presented at the European Breast Cancer Conference (EBCC-5).
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and KOKEN Co., Ltd., a leading atelocollagen company, announced today that Alnylam has granted KOKEN a non-exclusive worldwide license to manufacture and provide RNAi research products and services under the Kreutzer-Limmer patent family.
Genentech, a member of the Roche Group, and Biogen Idec today announced the U.S. Food and Drug Administration approved Rituxan as a maintenance treatment for patients with advanced follicular lymphoma who responded to initial treatment with Rituxan plus chemotherapy.
A recent study published on the preprint server medRxiv in October 2020 shows that among healthcare workers, and especially among first responders, less than 1% and just over 5%, respectively, had antibodies to the virus.
› Verified 5 days ago
| Entity Name | Allegheny Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073081493 PECOS PAC ID: 5395649586 Enrollment ID: O20040310000602 |
News Archive
A 30 year old woman diagnosed with breast cancer has the same chance of survival as a 60 year old woman with breast cancer according to the latest findings presented at the European Breast Cancer Conference (EBCC-5).
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and KOKEN Co., Ltd., a leading atelocollagen company, announced today that Alnylam has granted KOKEN a non-exclusive worldwide license to manufacture and provide RNAi research products and services under the Kreutzer-Limmer patent family.
Genentech, a member of the Roche Group, and Biogen Idec today announced the U.S. Food and Drug Administration approved Rituxan as a maintenance treatment for patients with advanced follicular lymphoma who responded to initial treatment with Rituxan plus chemotherapy.
A recent study published on the preprint server medRxiv in October 2020 shows that among healthcare workers, and especially among first responders, less than 1% and just over 5%, respectively, had antibodies to the virus.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Street, DO 147 Towne Square Way, Pittsburgh, PA 15227-3254 Ph: (412) 942-1085 | Rebecca Street, DO 147 Towne Square Way, Pittsburgh, PA 15227 Ph: (412) 942-1085 |
News Archive
A 30 year old woman diagnosed with breast cancer has the same chance of survival as a 60 year old woman with breast cancer according to the latest findings presented at the European Breast Cancer Conference (EBCC-5).
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and KOKEN Co., Ltd., a leading atelocollagen company, announced today that Alnylam has granted KOKEN a non-exclusive worldwide license to manufacture and provide RNAi research products and services under the Kreutzer-Limmer patent family.
Genentech, a member of the Roche Group, and Biogen Idec today announced the U.S. Food and Drug Administration approved Rituxan as a maintenance treatment for patients with advanced follicular lymphoma who responded to initial treatment with Rituxan plus chemotherapy.
A recent study published on the preprint server medRxiv in October 2020 shows that among healthcare workers, and especially among first responders, less than 1% and just over 5%, respectively, had antibodies to the virus.
› Verified 5 days ago
Genevieve Q Hunkele, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4815 Liberty Ave Ste M54, Pittsburgh, PA 15224 Phone: 412-621-1818 Fax: 412-621-4337 | |
Zenaida Rosado, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 300 Halket St, Suite 5120, Pittsburgh, PA 15213 Phone: 412-641-6476 | |
Beth Ann Prairie, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4815 Liberty Ave Ste Gr30, Pittsburgh, PA 15224 Phone: 412-854-7140 Fax: 412-854-7142 | |
Leiren Pantages, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 300 Halket St Ste 1750, Suite 1750, Pittsburgh, PA 15213 Phone: 412-641-5411 | |
Vasanti Harshit Majmudar, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9104 Babcock Blvd, Suite 5113, Pittsburgh, PA 15237 Phone: 412-364-4184 | |
Katharine M Goetz, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3380 Blvd Of The Allies, Suite 1, Pittsburgh, PA 15213 Phone: 412-621-7575 Fax: 412-621-6353 | |
Dr. Devayani I Pandit, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4815 Liberty Ave, Suite 340, Pittsburgh, PA 15224 Phone: 412-621-3211 Fax: 412-621-1428 |